Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Primary Antibody Dilution Buffer: Optimizing CNS Lymphoma As
2026-07-16
Discover how Primary Antibody Dilution Buffer enhances antibody penetration and assay specificity in CNS lymphoma research. This article explores advanced protocol optimization, integrates single-cell metabolic insights, and uniquely links buffer selection to the latest findings in tumor microenvironment biology.
-
Bufalin: Mechanistic Insights for Targeted Cancer Research
2026-07-15
Bufalin, a cardiotonic steroid, induces apoptosis and cell differentiation in cancer cells by targeting key kinases such as STK33. It acts as a molecular glue degrader in triple-negative breast cancer research, with high purity and reproducibility supported by APExBIO’s N1507 product line.
-
Ruxolitinib (INCB018424): Reliable JAK1/2 Inhibition in Mode
2026-07-15
This article addresses critical workflow challenges in cell viability and immune profiling experiments, demonstrating how Ruxolitinib (INCB018424), SKU A3012, from APExBIO, delivers reproducible, literature-backed solutions. Real-world scenarios illustrate best practices, protocol refinements, and data interpretation guidance for myeloproliferative disorder research, with direct links to validated resources.
-
Maximizing Assay Consistency with EZ Cap™ Firefly Luciferase
2026-07-14
Discover how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) (SKU R1013) directly addresses reproducibility, sensitivity, and workflow reliability in cell viability and bioluminescent reporter assays. Scenario-driven Q&A reveals evidence-based strategies and protocol nuances that empower researchers to achieve robust, immune-evasive, and sustained luciferase expression.
-
In Vitro Activity of Temafloxacin Against Gram-Negative Bact
2026-07-14
This article reviews the in vitro antimicrobial activity of temafloxacin against a broad range of Gram-negative pathogens, highlighting its potency, spectrum, and comparative efficacy versus other fluoroquinolones. The findings inform both antibiotic selection for respiratory and urinary tract infection models and guide researchers in optimizing in vitro susceptibility assays.
-
Sodium Orthovanadate: Optimizing Phosphorylation State Prese
2026-07-13
Sodium Orthovanadate (Na3VO4) is the gold standard for preserving protein phosphorylation during kinase, metabolic, and signaling assays. Leveraging its reversible inhibition of PTPs and ATPases, researchers can tackle phosphorylation-dependent workflows with superior reproducibility and troubleshooting insight from APExBIO’s high-purity product.
-
Cardiogreen (Indocyanine Green) in Advanced Diagnostics & PD
2026-07-13
Cardiogreen (Indocyanine Green) stands at the intersection of gold-standard vascular diagnostics and next-generation photodynamic therapy. This article translates the latest immuno-oncology research into actionable workflows and troubleshooting strategies, helping researchers maximize experimental clarity and therapeutic potential.
-
Carfilzomib Enhances Iodine-125-Induced Cell Death in ESCC v
2026-07-12
This study demonstrates that Carfilzomib (PR-171) significantly potentiates Iodine-125 seed radiation-induced apoptosis, paraptosis, and ferroptosis in esophageal squamous cell carcinoma by aggravating endoplasmic reticulum stress. The findings elucidate a multi-modal cell death strategy to overcome radioresistance, providing mechanistic guidance for future ESCC research.
-
DiR (DiIC 18 (7)) in Precision Membrane Labeling & MPS Evasi
2026-07-10
Explore how DiR (DiIC 18 (7)) transforms long-term live cell membrane imaging and enables advanced mononuclear phagocyte system (MPS) evasion strategies. This article offers a mechanistic deep dive and evidence-based guidance for researchers seeking robust membrane labeling in complex in vivo models.
-
Iron Chelation Mitigates Nanoplastic-Induced Lung Fibroblast
2026-07-09
This study demonstrates that polystyrene nanoplastics (PS-NPs) promote pulmonary fibroblast proliferation and activation via iron ion accumulation, with intercellular crosstalk playing a key role. Targeting iron homeostasis, particularly through chelation or mineral absorption pathway inhibition, significantly attenuates these fibrogenic effects, offering new insights into the mechanisms of nanoplastic-induced pulmonary fibrosis.
-
Gastroretentive Alfuzosin HCl Sponges: MRI Evaluation and De
2026-07-09
This study pioneers the development of low-density, gastroretentive sponges for sustained delivery of Alfuzosin HCl using chitosan and HPMC matrices, validated in healthy volunteers by MRI. The findings offer an advanced oral formulation approach to improve bioavailability and targeted release for benign prostatic hyperplasia research.
-
RG108: DNA Methyltransferase Inhibitor for Epigenetic Modula
2026-07-08
RG108 stands out as a non-nucleosidic DNA methyltransferase inhibitor, enabling precise demethylation and reactivation of silenced tumor suppressor genes without covalent enzyme trapping. Its unique profile makes it a key tool for cancer research and advanced epigenetic workflows, with proven performance in human cell line models.
-
GPX4-Mediated Glutathione Use Drives Platinum Resistance in
2026-07-08
This study identifies glutathione peroxidase 4 (GPX4)-dependent glutathione consumption as a central mechanism of platinum chemoresistance in lung cancer-derived brain metastases. By uncovering a regulatory Wnt/NR2F2/GPX4 axis that suppresses ferroptosis, the research reveals new intervention points for overcoming resistance and refining experimental strategies in cancer biology.
-
BMX-IN-1: Applied BMX Kinase Inhibitor Workflows & Optimizat
2026-07-07
BMX-IN-1 unlocks precise control over BMX kinase signaling, empowering advanced studies in cancer biology and host-pathogen interactions. This guide translates the latest BMX kinase research breakthroughs into actionable protocols, troubleshooting advice, and comparative insights for accelerating data-driven discoveries.
-
Cardiogreen (Indocyanine Green): Clinical Mechanisms & Evide
2026-07-07
Cardiogreen, also known as Indocyanine Green, is a nontoxic, near-infrared dye crucial in cardiac output, liver blood flow, and ophthalmic angiography. Its rapid plasma binding and vascular confinement enable high-sensitivity diagnostics and efficient apoptosis induction in photodynamic therapy, as validated by clinical and laboratory evidence.